Microbiology of Para- og Retropharyngeal Abscess

NCT02640456 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2016-04-27

No results posted yet for this study

Summary

The aims of the study are:

1. Explore the bacteriology of para- and retropharyngeal abscess.
2. Validate the bacterial findings by exploring antibody development against F. necrophorum, F. nucleatum and S. pyogenes.
3. Compare bacteriologic findings in concomitant peritonsillar and parapharyngeal abscesses.
4. Characterize patients with para- and retropharyngeal abscess.
5. Compare the concentration of amylase in para- and retropharyngeal abscesses and neck abscesses without relation to the pharynx or salivary glands.
6. Perform gene-sequencing of F. Necrophorum strains, and compare these with strains recovered from patients with acute tonsillitis, peritonsillar abscess, and Lemierre´s syndrome.

Conditions

  • Retropharyngeal Abscess

Interventions

BIOLOGICAL

Bacteriology

Tonsillar surface swabs, tonsillar tissues, and pus aspirates.

PROCEDURE

Type of surgery

Surgical approach and complications.

BIOLOGICAL

Biochemistry

Amylase concentration i pus aspirates.

BIOLOGICAL

Serology

Levels of antibodies against selected bacteria (F. necrophorum, F. nucleatum, and Group A streptococci) in acute and convalescent sera.

Sponsors & Collaborators

  • Hospitalsenheden Vest

    collaborator OTHER
  • Aalborg University Hospital

    collaborator OTHER
  • Sygehus Lillebaelt

    collaborator OTHER
  • Aarhus University Hospital

    collaborator OTHER
  • Statens Serum Institut

    collaborator OTHER
  • University of Aarhus

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Tejs Ehlers Klug

    lead OTHER

Principal Investigators

  • Tejs E Klug, MD · Aarhus University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02640456 on ClinicalTrials.gov